Dr. Katia Bruxvoort headshot

Katia Bruxvoort, PhD, MPH

Adjunct Investigator

Division of Epidemiologic Research




Dr. Katia Bruxvoort is an infectious disease epidemiologist. She is a co-investigator on several post-licensure vaccine safety and effectiveness studies (hepatitis B vaccine, shingles vaccine, influenza vaccines). Other current research includes understanding patterns of antimicrobial use and resistance in urinary tract infections and improving uptake and adherence to pre-exposure prophylaxis (PrEP) for HIV. She has broad interests in infectious disease prevention, targeted treatment, and the intersection of social needs and health.

She was a post-doctoral research fellow for the Department of Research & Evaluation from 2017 to 2021. Before joining Kaiser Permanente, Dr. Bruxvoort worked in Tanzania as an epidemiologist with the London School of Hygiene and Tropical Medicine. She led large-scale studies to evaluate the national rollout of malaria rapid diagnostic tests and tested novel interventions to improve adherence to antimalarial treatment.

Areas of Focus

  • Infectious diseases
  • Vaccine safety and effectiveness
  • Antimicrobial resistance
  • Medication adherence


PhD, Epidemiology
London School of Hygiene and Tropical Medicine
London, United Kingdom
MPH, Global Epidemiology
Emory University
Atlanta, Georgia

Honors and Awards

  • Young Investigator Honorable Mention, American Society of Tropical Medicine and Hygiene